BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9161517)

  • 1. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
    Pascal JP
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
    [No Abstract]   [Full Text] [Related]  

  • 2. [Should hepatitis C be treated? Which biological tests are useful before deciding or refuting a treatment with interferon-alpha in patients with chronic hepatitis C?].
    Pawlotsky JM
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S41-50. PubMed ID: 9161513
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 4. [How to follow treated and untreated chronic hepatitis B and C].
    Adler M; Golstein P; Botembe N; Bourgeois N
    Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing patients with hepatitis C.
    Drug Ther Bull; 1993 Aug; 31(16):61-2. PubMed ID: 8375275
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C. The surprise infectious disease of the decade.
    Mayo Clin Health Lett; 1998 Feb; 16(2):6. PubMed ID: 9516363
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hepatitis C in patients who have decompensated cirrhosis.
    Everson GT
    Clin Liver Dis; 2005 Aug; 9(3):473-86, viii. PubMed ID: 16023978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Should hepatitis C be treated?].
    Tran A
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S148-53. PubMed ID: 9161526
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Should Hepatitis C be treated? Objectives of antiviral treatments in hepatitis C virus infection].
    Degos F
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S57-65. PubMed ID: 9161515
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monitoring of treated or non-treated chronic viral hepatitis C. 2: Criteria of efficacy and monitoring of treatment with interferon-alpha].
    Payen JL
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S175-89. PubMed ID: 9161529
    [No Abstract]   [Full Text] [Related]  

  • 12. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
    Larrey D
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
    [No Abstract]   [Full Text] [Related]  

  • 13. Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy.
    Ono SK; da Silva LC; Carrilho FJ; da Fonseca LE; Mendes LC; Madruga CL; Farias Ade Q; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(5):180-3. PubMed ID: 9216095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How should hepatitis C be treated? Treatment of hepatitis C with interferon].
    Marcellin P
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S81-8. PubMed ID: 9161518
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U; Niederau C; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern.
    Morosetti M; Sciarra G; Meloni C; Palmieri G; Palombo G; Taccone Gallucci M; Casciani CU
    Nephrol Dial Transplant; 1996 Mar; 11(3):532-4. PubMed ID: 8671827
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic hepatitis C: therapeutic uncertainties].
    Blondon H; Bergmann JF
    Gastroenterol Clin Biol; 1996; 20(12):1043-6. PubMed ID: 9033847
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon alpha in hepatitis C: a cytokine for reducing fibrosis progression.
    Poynard T
    Eur Cytokine Netw; 1997 Sep; 8(3):319-20. PubMed ID: 9346374
    [No Abstract]   [Full Text] [Related]  

  • 20. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M; Yanaga K; Morizane T; Yanagawa T; Hirakawa M; Ueno Y; Esquivel CO; Mitamura K
    J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.